BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 14531955)

  • 1. Atherosclerotic cardiovascular disease in rheumatoid arthritis.
    del Rincón I; Escalante A
    Curr Rheumatol Rep; 2003 Aug; 5(4):278-86. PubMed ID: 14531955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular disease in rheumatoid arthritis.
    Kaplan MJ
    Curr Opin Rheumatol; 2006 May; 18(3):289-97. PubMed ID: 16582694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rheumatoid arthritis--a risk factor of ischemic heart disease].
    Hollan I; Mikkelsen K; Førre Ø
    Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3259-62. PubMed ID: 16327849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity.
    Landewé RB; van den Borne BE; Breedveld FC; Dijkmans BA
    Lancet; 2000 May; 355(9215):1616-7. PubMed ID: 10821370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.
    Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
    Ann Rheum Dis; 2015 Mar; 74(3):480-9. PubMed ID: 25561362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate treatment and mortality in rheumatoid arthritis.
    Rewald E; de las Mercedes Francischetti M
    Lancet; 2002 Oct; 360(9339):1097. PubMed ID: 12384012
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular disease in rheumatoid arthritis: disease and treatment interactions and their implications on treatment decisions.
    Sanders S; Geraci SA
    J Miss State Med Assoc; 2010 Mar; 51(3):75-80. PubMed ID: 20827876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tackling ischaemic heart disease in rheumatoid arthritis.
    Kitas GD; Erb N
    Rheumatology (Oxford); 2003 May; 42(5):607-13. PubMed ID: 12709534
    [No Abstract]   [Full Text] [Related]  

  • 9. [Accelerated atherosclerosis in rheumatoid arthritis].
    Shepshelovich D; Sherer Y; Shoenfeld Y
    Harefuah; 2005 Aug; 144(8):561-3, 598. PubMed ID: 16146154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular Manifestations in Rheumatoid Arthritis.
    Sanghavi N; Ingrassia JP; Korem S; Ash J; Pan S; Wasserman A
    Cardiol Rev; 2024 Mar-Apr 01; 32(2):146-152. PubMed ID: 36729119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of carotid ultrasonography in the assessment of subclinical atherosclerosis and the paradoxical effect of corticosteroids on atherosclerosis in patients with rheumatoid arthritis.
    Gonzalez-Gay MA; Gonzalez-Juanatey C; Vazquez-Rodriguez TR; Llorca J
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S141; author reply S141. PubMed ID: 19646362
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of traditional therapies and biologics on cardiovascular diseases in rheumatoid arthritis.
    Boyer JF; Cantagrel A; Constantin A
    Curr Vasc Pharmacol; 2008 Jul; 6(3):218-27. PubMed ID: 18673161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk in rheumatoid arthritis: how to lower the risk?
    van Breukelen-van der Stoep DF; Klop B; van Zeben D; Hazes JM; Castro Cabezas M
    Atherosclerosis; 2013 Nov; 231(1):163-72. PubMed ID: 24125429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk in rheumatoid arthritis.
    Nurmohamed MT
    Autoimmun Rev; 2009 Jul; 8(8):663-7. PubMed ID: 19393192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 6 Inhibition and Coronary Artery Disease in a High-Risk Population: A Prospective Community-Based Clinical Study.
    Bacchiega BC; Bacchiega AB; Usnayo MJ; Bedirian R; Singh G; Pinheiro GD
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28288972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
    Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
    J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflamed joints and stiff arteries: is rheumatoid arthritis a cardiovascular risk factor?
    Quyyumi AA
    Circulation; 2006 Sep; 114(11):1137-9. PubMed ID: 16966595
    [No Abstract]   [Full Text] [Related]  

  • 18. Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.
    Avalos I; Rho YH; Chung CP; Stein CM
    Clin Exp Rheumatol; 2008; 26(5 Suppl 51):S5-13. PubMed ID: 19026140
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship Between Risk of Atherosclerotic Cardiovascular Disease, Inflammation, and Coronary Microvascular Dysfunction in Rheumatoid Arthritis.
    Weber B; Weisenfeld D; Seyok T; Huang S; Massarotti E; Barrett L; Bibbo C; Solomon DH; Plutzky J; Bolster M; Di Carli M; Liao KP
    J Am Heart Assoc; 2022 Jun; 11(11):e025467. PubMed ID: 35657008
    [No Abstract]   [Full Text] [Related]  

  • 20. Rheumatoid Arthritis Pharmacotherapies: Do They Have Anti-Atherosclerotic Activity?
    Giles JT
    Curr Rheumatol Rep; 2016 May; 18(5):27. PubMed ID: 27032790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.